The Sarcoma Biology and Outcome Project
A Prospective Registry Study on Biological Disease Profile, Intervention Type and Clinical Outcome in Adolescent and Adult Patients With Soft-tissue and Bone Sarcoma
Prof. Dr. Richard F Schlenk
3,000 participants
Jul 23, 2019
OBSERVATIONAL
Conditions
Summary
SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.
Eligibility
Inclusion Criteria5
- Suspected or proven diagnosis of soft-tissue or bone sarcoma (STBS)
- Age ≥12 years
- Ability to understand nature and individual consequences of the registry
- Written informed consent
- Subjects who are physically or mentally capable of giving consent
Exclusion Criteria1
- • Severe neurological or psychiatric disorder interfering with the ability to give written informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04758325